J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
India
· Delayed Price · Currency is INR | Market Cap | 257.40B |
| Revenue (ttm) | 39.18B |
| Net Income (ttm) | 6.60B |
| Shares Out | n/a |
| EPS (ttm) | 41.56 |
| PE Ratio | 39.02 |
| Forward PE | 31.96 |
| Dividend | 15.50 (0.96%) |
| Ex-Dividend Date | Jul 30, 2025 |
| Volume | 291,737 |
| Average Volume | 456,767 |
| Open | 1,642.00 |
| Previous Close | 1,650.10 |
| Day's Range | 1,642.00 - 1,665.00 |
| 52-Week Range | 1,385.75 - 2,030.00 |
| Beta | -0.09 |
| RSI | 48.18 |
| Earnings Date | Aug 3, 2025 |
About NSE:JBCHEPHARM
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company’s API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and h... [Read more]
Financial Performance
In 2024, NSE:JBCHEPHARM's revenue was 39.18 billion, an increase of 12.45% compared to the previous year's 34.84 billion. Earnings were 6.60 billion, an increase of 19.35%.
Financial StatementsNews
Torrent Pharmaceuticals to acquire additional 2.41% stake in JB Chemicals for Rs 620 crore
Torrent Pharmaceuticals Limited has announced that it will acquire up to 2.41% of the equity share capital of JB Chemicals & Pharmaceuticals Limited (JB Chemicals) for a total consideration of approxi...
Torrent set to be 5th largest pharma co
India Business News: New Delhi: Following the acquisition of JB Chemicals & Pharmaceuticals (JB Chem), Torrent Pharma is set to become India's fifth-largest pharmaceut.
Torrent Pharma becomes India’s 5th largest drugmaker
Torrent Pharma's acquisition of JB Chemicals & Pharmaceuticals propels it to become India's fifth-largest pharmaceutical company, capturing a 4.6% market share. This deal significantly strengthens Tor...
Meta, KKR, Lululemon And An Industrial Stock On CNBC's 'Final Trades'
On CNBC's “ Halftime Report Final Trades ,” Bryn Talkington , managing partner of Requisite Capital Management, said KKR & Co. Inc. (NYSE: KKR) is in big-time fundraising mode. The stock will go high...
Torrent in Rs 18,000 crore deal, 2nd largest in pharma sector
Torrent Pharma is set to acquire a controlling stake in JB Chemicals & Pharmaceuticals for approximately Rs 18,000 crore, marking the second-largest pharma deal in India. The acquisition involves purc...
India's Torrent to buy controlling stake in JB Chemicals from KKR for $1.4B
Torrent Pharma revives talks to buy KKR stake in JB Chem
India Business News: NEW DELHI: Ahmedabad-based Torrent Pharma has revived talks with PE major KKR to buy its stake in Mumbai-based JB Chemicals & Pharmaceuticals in a.
Top stocks in focus on June 25: JB Chemicals, Infosys, PTC Industries, HAL, IRCTC, and more
The Indian stock market is set for an eventful session on Wednesday, June 25, with several companies announcing fresh developments that could draw investor attention. Here’s a look at key corporate ne...
Stocks in news: HDFC Bank, ICICI Bank, Emcure Pharma, TCS, NIIT, Adani Ports, Zydus, Adani Green among top stocks to watch on April 21
A packed day for equity markets awaits investors with multiple stocks poised to remain in focus today, driven by corporate developments, quarterly earnings announcements, and rating upgrades. In the p...
JB Chemicals & Pharma shares slide 6% after large block deal of 5.7% equity
Shares of JB Chemicals & Pharmaceuticals declined sharply on Thursday, falling 6.68% to ₹1,594.65 on the NSE, following a large block deal involving 5.78% equity. As per exchange data, around 90 lakh ...
Stocks to watch today: Infosys, Wipro, Ashok Leyland, HUL, Bajaj Finance, BSE, NBCC, UPL, Max Financial, JB Chemicals in focus [27 March]
Indian equity markets are likely to witness stock-specific action on Thursday, March 27, as several companies announced key developments, strategic deals, stake sales, and corporate updates. Here’s a ...
Stocks to watch today: JB Chemicals, Infosys, Bajaj Finserv, Wipro, Bharat Forge, Marico, Sterlite Technologies in focus on March 26, 2025
Several key corporate announcements are set to drive investor attention on March 26, with developments across IT, pharma, defence, infra, and financial services sectors. Here are the top stocks likely...
KKR, JB Chemicals promoter, to sell 10% for Rs 2.6k crore
India Business News: MUMBAI: Tau Investment Holdings, an arm of global private equity major KKR, the promoter of JB Chemicals, is selling about 1.
JB Chemicals and Pharma: Promoter KKR entity to sell 10.2% stake worth Rs 2,575 crore via block tomorrow
Shares of JB Chemicals & Pharmaceuticals Ltd are likely to remain in focus following media reports from CNBC-Awaaz suggest a large block deal has been launched by promoter group entity Tau Investment ...
KKR Is Said to Consider Selling $750 Million Stake in JB Pharma
KKR & Co. is considering selling some of its controlling stake in JB Chemicals & Pharmaceuticals Ltd. via a block trade in the market, according to people familiar with the matter.
Stocks to Buy This Diwali: Kotak Securities sees JB Chemicals & Pharma reaching ₹2,255, with a 19.2% upside
Kotak Securities has added JB Chemicals & Pharma to its Diwali 2024 stock picks, assigning it a “Buy” rating with a target price of ₹2,255. Currently trading at ₹1,891, JB Chemicals offers an upside p...
Pharma Stocks Update: Natco Pharma gains 2.99%, Glenmark rises 0.07%, Granules falls 3.83%
As of 2:38 PM, the Nifty Pharma index saw a mixed performance with some stocks showing notable gains while others faced losses. Natco Pharma, Glenmark, and Ajanta Pharma were the top gainers, while Gr...
Pharma Stocks Update: Granules up 3.56%, Ajanta Pharma gains 2.24% while JB Chemicals drops 2.82%, Mankind Pharma down 1.40% in mixed pharma stock performance
Pharma stocks have shown mixed performance in today’s trading session, with some major players gaining ground while others face declines. As of now, here’s how key pharmaceutical stocks are performing...
JB Chemicals faces valuation dispute over KKR’s 54% equity stake, potential M&A deal withdrawal looms; stock falls 4.28%
The largest M&A deal in India’s pharmaceutical industry for 2024 is reportedly facing significant hurdles. According to ET Now, JB Chemicals is in a disagreement over the valuation of KKR’s 54% equity...